Safety and Efficacy of VAY736 in Patients With Primary Sjogren’s Syndrome (pSS)

https://www.clinicaltrials.gov/ct2/show/NCT02962895 Safety and Efficacy of VAY736 in Patients With Primary Sjogren’s Syndrome (pSS) Brief Summary: This study will determine the dose-response relationship of VAY736 for key efficacy and safety parameters Condition or disease Intervention/treatment Phase Primary Sjogren Syndrome Biological: VAY736 Other: Placebo Phase 2 Study Design Go to sections Study Type : Interventional (Clinical Trial) […]